367 related articles for article (PubMed ID: 31829234)
1. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial allocation in multinational pharmaceutical companies - a qualitative study on influential factors.
Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
Pharmacol Res Perspect; 2017 Jun; 5(3):e00317. PubMed ID: 28603635
[TBL] [Abstract][Full Text] [Related]
3. Success and failure factors of patient recruitment for industry-sponsored clinical trials and the role of the electronic health records-a qualitative interview study in the Nordic countries.
Laaksonen N; Bengtström M; Axelin A; Blomster J; Scheinin M; Huupponen R
Trials; 2022 May; 23(1):385. PubMed ID: 35550003
[TBL] [Abstract][Full Text] [Related]
4. Interactions between physicians and the pharmaceutical industry: what does the literature say?
Lexchin J
CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
[TBL] [Abstract][Full Text] [Related]
5. Managing clinical grant costs.
Glass HE; Hollander K
Contemp Clin Trials; 2009 May; 30(3):221-6. PubMed ID: 19470309
[TBL] [Abstract][Full Text] [Related]
6. Budget negotiation for industry-sponsored clinical trials.
Beal K; Dean J; Chen J; Dragaon E; Saulino A; Collard CD
Anesth Analg; 2004 Jul; 99(1):173-176. PubMed ID: 15281525
[TBL] [Abstract][Full Text] [Related]
7. Assessing Study Start-up Practices, Performance, and Perceptions Among Sponsors and Contract Research Organizations.
Lamberti MJ; Wilkinson M; Harper B; Morgan C; Getz K
Ther Innov Regul Sci; 2018 Sep; 52(5):572-578. PubMed ID: 29714558
[TBL] [Abstract][Full Text] [Related]
8. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
[TBL] [Abstract][Full Text] [Related]
9. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
Lundh A; Krogsbøll LT; Gøtzsche PC
Trials; 2012 Aug; 13():146. PubMed ID: 22920226
[TBL] [Abstract][Full Text] [Related]
10. Are results from pharmaceutical-company-sponsored studies available to the public?
Dal-Ré R; Pedromingo A; García-Losa M; Lahuerta J; Ortega R
Eur J Clin Pharmacol; 2010 Nov; 66(11):1081-9. PubMed ID: 20844869
[TBL] [Abstract][Full Text] [Related]
11. Industry sponsorship and research outcome.
Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
[TBL] [Abstract][Full Text] [Related]
12. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial site identification practices and the use of electronic health records in feasibility evaluations: An interview study in the Nordic countries.
Laaksonen N; Bengtström M; Axelin A; Blomster J; Scheinin M; Huupponen R
Clin Trials; 2021 Dec; 18(6):724-731. PubMed ID: 34431408
[TBL] [Abstract][Full Text] [Related]
14. Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: cross sectional descriptive study and pilot of a tool to improve company practices.
Miller J; Ross JS; Wilenzick M; Mello MM
BMJ; 2019 Jul; 366():l4217. PubMed ID: 31292127
[TBL] [Abstract][Full Text] [Related]
15. Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.
Psotka MA; Ammon SE; Fiuzat M; Bozkurt B; Chung ES; Cole RT; Greene SJ; Kraus D; Ky B; McIlvennan CK; Shah P; Teerlink JR; Walsh MN; Jessup M; O'Connor CM
JACC Heart Fail; 2019 May; 7(5):431-438. PubMed ID: 30981742
[TBL] [Abstract][Full Text] [Related]
16. What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK.
Duley L; Gillman A; Duggan M; Belson S; Knox J; McDonald A; Rawcliffe C; Simon J; Sprosen T; Watson J; Wood W
Trials; 2018 Jan; 19(1):15. PubMed ID: 29310685
[TBL] [Abstract][Full Text] [Related]
17. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.
Safer DJ
J Nerv Ment Dis; 2002 Sep; 190(9):583-92. PubMed ID: 12357091
[TBL] [Abstract][Full Text] [Related]
18. Barriers to participation in industry-sponsored clinical trials in pediatric type 2 diabetes.
Farrell R; Bethin K; Klingensmith G; Tamborlane WV; Gubitosi-Klug R
Pediatr Diabetes; 2017 Nov; 18(7):574-578. PubMed ID: 27807915
[TBL] [Abstract][Full Text] [Related]
19. Clinical drug trials in general practice: a 10-year overview of protocols.
Brænd AM; Jensen KB; Klovning A; Straand J
Trials; 2013 Jun; 14():162. PubMed ID: 23725228
[TBL] [Abstract][Full Text] [Related]
20. The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.
Schott G; Pachl H; Limbach U; Gundert-Remy U; Ludwig WD; Lieb K
Dtsch Arztebl Int; 2010 Apr; 107(16):279-85. PubMed ID: 20467553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
